Insider Transactions in Q1 2024 at Krystal Biotech, Inc. (KRYS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.22%
|
$4,275,000
$171.04 P/Share
|
|
Mar 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.23%
|
$4,275,000
$171.18 P/Share
|
|
Mar 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.23%
|
$4,275,000
$171.18 P/Share
|
|
Mar 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.22%
|
$4,275,000
$171.04 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,314
-12.9%
|
$377,182
$163.08 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+4.45%
|
$1,050,000
$60.9 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.93%
|
$2,075,000
$166.99 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,785
-0.35%
|
$942,955
$163.08 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Indirect |
12,500
+0.76%
|
-
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,471
-0.22%
|
$565,773
$163.08 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.47%
|
-
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,471
-0.22%
|
$565,773
$163.08 P/Share
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,500
+0.47%
|
-
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,785
-0.35%
|
$942,955
$163.08 P/Share
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+0.76%
|
-
|
|
Feb 27
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,913
+12.88%
|
$99,476
$52.26 P/Share
|
|
Feb 26
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-0.15%
|
$369,421
$157.0 P/Share
|
|
Feb 26
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-12.21%
|
$240,681
$157.0 P/Share
|
|
Feb 26
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,087
-24.11%
|
$1,107,919
$137.5 P/Share
|
|
Feb 26
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,087
+19.32%
|
$420,524
$52.26 P/Share
|
|
Feb 26
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,791
-0.23%
|
$595,187
$157.0 P/Share
|
|
Jan 22
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,500
-16.6%
|
$325,000
$130.0 P/Share
|
|
Jan 22
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+14.24%
|
$130,000
$52.26 P/Share
|